Fora Capital, LLC Allogene Therapeutics, Inc. Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $86,077 - $113,241	-4,097 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $96,238 - $146,672	4,097 New	4,097 $107 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $103,985 - $157,328	-4,032 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$25.24 - $43.45 $101,767 - $175,190	4,032 New	4,032 $101,000
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $95,423 - $132,497	-2,947 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $54,195 - $159,255	2,947 New	2,947 $126 Million

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.